GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
Recruiting · NCT07021209 · Registry updated 2026-09-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases | Neurological Autoimmune Diseases | Recruiting | Phase 1 | 2026-09-11 | NCT07021209 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Grit Biotechnology | 19 |
| Tongji Hospital | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 3 |